TSPY1 and prostate cancer: Multiple CT‐X antigens (e.g., MAGEA, CT1; GAGE, CT4; NY‐ESO‐1, CT6; PAGE, CT16; and TSPY1, CT78) are highly expressed in prostate cancer accompanied by DNA demethylation, and changes in DNA methylation status are associated with tumor metastasis.14